清科創業(1945.HK)連續第二日大幅反彈
格隆匯2月5日丨繼昨日收漲8.9%後,次新股清科創業(1945.HK)今日盤中再度拉昇,一度漲10.56%報7.75港元,市值24億港元。公司是中國最大的股權投資綜合服務平台,格隆匯平台昨日推出分析文章稱,該股前期的下跌或是受獲利盤出逃所致,但隨着股價走向築底階段,當下實際上已留下了不錯的安全邊際,這主要是基於公司目前破發狀態下,上市公開招股的基石投資者賬面已經浮虧,而這其中不乏投資圈大名鼎鼎的高瓴、盈科、IDG等。這些基石投資者均設有六個月的禁售期,這也意味着在禁售期後,倘若基石投資者有退出的想法,相信這些大名鼎鼎的機構也一定不會甘心虧損離場。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.